Plasma phospholipids and prevalence of mild cognitive impairment and/or dementia in the ARIC Neurocognitive Study (ARIC-NCS).
about
Current and Future Perspectives on the Structural Identification of Small Molecules in Biological SystemsProspective associations of plasma phospholipids and mild cognitive impairment/dementia among African Americans in the ARIC Neurocognitive Study.Progress in Metabolomics Standardisation and its Significance in Future Clinical Laboratory MedicineMetabolic network failures in Alzheimer's disease: A biochemical road map.Metabolomics and cognition in African American adults in midlife: the atherosclerosis risk in communities study.Introduction to special issue on Advances in blood-based biomarkers of Alzheimer's disease.Independent association of plasma hydroxysphingomyelins with physical function in the Atherosclerosis Risk in Communities (ARIC) study.Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry.Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic.Alterations in the Plasma Levels of Specific Choline Phospholipids in Alzheimer's Disease Mimic Accelerated Aging.Association of branched-chain amino acids and other circulating metabolites with risk of incident dementia and Alzheimer's disease: A prospective study in eight cohorts.A Blood Test for Alzheimer's Disease: Progress, Challenges, and Recommendations.High-Throughput Direct Mass Spectrometry-Based Metabolomics to Characterize Metabolite Fingerprints Associated with Alzheimer's Disease Pathogenesis
P2860
Q28079837-66FBEAFF-220B-471A-BFE7-F93ECBA8BA00Q37543795-B26F9506-B4E7-4C77-BD23-196D58D75577Q37615997-0C8B43E8-9E9D-4B53-A57D-A7E94F28AEB4Q38877855-543D2DED-2490-433B-B169-1C11D3FCEA89Q41196957-8ECD836C-9B98-48FE-9AAD-8A7D1AF90A2EQ42414341-BA54FC8B-6AF7-41DF-A108-253286D0C77CQ46720033-5CE0690D-FF32-446D-A228-746905FF4EE3Q47587631-6DE35653-C794-4E65-83E8-7676B8D162E6Q49135523-F5936233-6136-4461-9BED-1588E6CE5E1AQ50417000-952AADD9-30B8-42D6-8BE2-BA7560769061Q51764769-54B97B13-A549-454F-85C7-2C2CFA2EBC74Q52609763-83D6107A-9A34-4FF8-B56A-A47750980E8EQ58723601-7E60033E-F7C1-415C-A890-FE287A76A4B7
P2860
Plasma phospholipids and prevalence of mild cognitive impairment and/or dementia in the ARIC Neurocognitive Study (ARIC-NCS).
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 May 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Plasma phospholipids and preva ...... urocognitive Study (ARIC-NCS).
@en
Plasma phospholipids and preva ...... the ARIC Neurocognitive Study
@nl
type
label
Plasma phospholipids and preva ...... urocognitive Study (ARIC-NCS).
@en
Plasma phospholipids and preva ...... the ARIC Neurocognitive Study
@nl
prefLabel
Plasma phospholipids and preva ...... urocognitive Study (ARIC-NCS).
@en
Plasma phospholipids and preva ...... the ARIC Neurocognitive Study
@nl
P2093
P2860
P50
P1476
Plasma phospholipids and preva ...... urocognitive Study (ARIC-NCS).
@en
P2093
A Richey Sharrett
Alvaro Alonso
Jeffrey R Misialek
Lisa M Wruck
P2860
P356
10.1016/J.DADM.2016.02.008
P577
2016-05-06T00:00:00Z